EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Rapid and Effective Elimination of Myoglobin with CytoSorb® Hemoadsorber in Patients with Severe Rhabdomyolysis

Frederic Albrecht, Stefan Schunk, Maren Fuchs, Thomas Volk, Juergen Geisel, Danilo Fliser, Andreas Meiser

Blood Purification · 2024 · 53 (2) · 88-95

DOI: 10.1159/000534479 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Blood Purification, online erschienen am 02.11.2023. Verfasst von Frederic Albrecht und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Saarland University Faculty of Medicine, Hombur…. Hauptthemen laut MEDLINE: Rhabdomyolysis, Continuous Renal Replacement Therapy, Acute Kidney Injury. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Rhabdomyolysis is characterized by destruction of muscle fibers by various causes and is diagnosed by increased creatine kinase concentrations in the blood. Myoglobin released into the blood may cause acute kidney injury. In this randomized controlled study, we hypothesized that myoglobin elimination would be faster when a hemoadsorber was added to a continuous veno-venous hemodialysis (CVVHD).

Methods

Four patients in the control group received CVVHD with a high cut-off hemofilter using high blood and dialysate flows for 48 h. Four patients in the CytoSorb group received the same treatment, but in addition, the hemoadsorber CytoSorb® was inserted in front of the hemofilter and replaced once after 24 h. Blood samples were drawn simultaneously before (pre) and after (post) the hemofilter or else the hemoadsorber, after 5 and 30 min, as well as after 2, 4, 8, and 24 h. All measurements were repeated the next day after the hemoadsorber had been renewed in the CytoSorb group. Primary outcome was the area under the curve (AUC) of the relative myoglobin concentrations as percent of baseline. To evaluate the efficacy of myoglobin removal, relative reductions in myoglobin concentrations during one passage through each device at each time point were calculated.

Results

Patients in the CytoSorb group had a significantly lower AUC during the first 24 h (42 ± 10% vs. 63 ± 6%, p = 0.029) as well as during the observation period of 48 h (26 ± 7% vs. 51 ± 12%, p = 0.029). The relative reductions for myoglobin were considerably higher in the CytoSorb group compared to the control group during the first 8 h.

Conclusion

Myoglobin concentrations declined considerably faster when CytoSorb was added to a CVVHD. When compared to a high-cut-off hemofilter, efficacy of CytoSorb in myoglobin elimination was much better. Because of saturation after 8–12 h an exchange may be necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhabdomyolysisContinuous Renal Replacement TherapyAcute Kidney InjuryHumansMyoglobin

Stichwörter der Autor:innen

Acute kidney injuryContinuous renal replacement therapyHemoadsorberMyoglobinRenal replacement therapyRhabdomyolysis

Substanzen

Myoglobin

Autor:innen und Institutionen

  • Department of Anesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany.
  • Department of Internal Medicine IV, Nephrology and Hypertension, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany.
  • Department of Clinical Chemistry and Laboratory Medicine, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany.

Zitieren

APA

Albrecht, F., Schunk, S., Fuchs, M., Volk, T., Geisel, J., Fliser, D., & Meiser, A. (2024). Rapid and Effective Elimination of Myoglobin with CytoSorb® Hemoadsorber in Patients with Severe Rhabdomyolysis. Blood Purification, 53(2), 88-95. https://doi.org/10.1159/000534479

Vancouver

Albrecht F, Schunk S, Fuchs M, Volk T, Geisel J, Fliser D, et al. Rapid and Effective Elimination of Myoglobin with CytoSorb® Hemoadsorber in Patients with Severe Rhabdomyolysis. Blood Purification. 2024;53(2):88-95. doi:10.1159/000534479

BibTeX
@article{Albrecht2024,
  author = {Albrecht, Frederic and Schunk, Stefan and Fuchs, Maren and Volk, Thomas and Geisel, Juergen and Fliser, Danilo and Meiser, Andreas},
  title = {Rapid and Effective Elimination of Myoglobin with CytoSorb® Hemoadsorber in Patients with Severe Rhabdomyolysis},
  journal = {Blood Purification},
  year = {2024},
  volume = {53},
  number = {2},
  pages = {88--95},
  doi = {10.1159/000534479}
}
Kostenlos starten →